Puig, L <br/><br/>
Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain.  [electronic resource] 

 -  Actas dermo-sifiliograficas   
 - 34-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1578-2190 
<br/><br/><label>Standard No.: </label>10.1016/j.ad.2015.07.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Biological Products--economics<br/>Decision Trees<br/>Etanercept--therapeutic use<br/>Humans<br/>Infliximab--therapeutic use<br/>Meta-Analysis as Topic<br/>Psoriasis--drug therapy<br/>Reproducibility of Results<br/>Spain<br/>Ustekinumab--therapeutic use